2008
DOI: 10.3181/0705-mr-134
|View full text |Cite
|
Sign up to set email alerts
|

Diabetic Nephropathy: Mechanisms of Renal Disease Progression

Abstract: Diabetic nephropathy is characterized by excessive amassing of extracellular matrix (ECM) with thickening of glomerular and tubular basement membranes and increased amount of mesangial matrix, which ultimately progress to glomerulosclerosis and tubulo-interstitial fibrosis. In view of this outcome, it would mean that all the kidney cellular elements, i.e., glomerular endothelia, mesangial cells, podocytes, and tubular epithelia, are targets of hyperglycemic injury. Conceivably, high glucose activates various p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
455
0
7

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 539 publications
(468 citation statements)
references
References 61 publications
6
455
0
7
Order By: Relevance
“…The ability to switch phenotype stems from a unique plasticity of epithelial cells that has, up until recently, been universally accepted as the sole driving force behind the generation of interstital fibroblasts in kidney disease. EMT of proximal tubule cells (PTC) has been clearly documented in DN, with overwhelming evidence implicating the cytokine Transforming Growth Factor-beta 1 (TGF-β1) as the key mediator [15][16]. Our knowledge of the pathology of TGF-β1 in the kidney is extensive however, the majority of this research is dedicated to exploring the consequences of TGF-β1 signalling in glomerular cells, mesangial cells or podocytes.…”
Section: Introductionmentioning
confidence: 99%
“…The ability to switch phenotype stems from a unique plasticity of epithelial cells that has, up until recently, been universally accepted as the sole driving force behind the generation of interstital fibroblasts in kidney disease. EMT of proximal tubule cells (PTC) has been clearly documented in DN, with overwhelming evidence implicating the cytokine Transforming Growth Factor-beta 1 (TGF-β1) as the key mediator [15][16]. Our knowledge of the pathology of TGF-β1 in the kidney is extensive however, the majority of this research is dedicated to exploring the consequences of TGF-β1 signalling in glomerular cells, mesangial cells or podocytes.…”
Section: Introductionmentioning
confidence: 99%
“…Overexpression of the ECM components (FN and ColIV) and TGF-b1 has been previously implicated in the development of the renal fibrosis of DN. 18 FN, the first dimeric glycoprotein found in ECM with a molecular weight of 550 kD, contains five spherical functional domains that can bind heparin, collagen, and cell surface receptors. Because of its binding capacity, FN links ECM with the intracellular cytoskeleton and provides trestle structure for other ECM components.…”
Section: Effects Of Nctd On Can/nfatc Signaling Pathway In Hk-2 Cellsmentioning
confidence: 99%
“…Central to this process is epithelial-to-mesenchymal transition (EMT) or the trans-differentiation of tubular epithelial cells into myofibroblasts [3][4][5]. Overwhelming evidence implicates TGF-β1 as the predominant cytokine mediating these phenotypical fibrotic changes [6,7]. In diabetes, production of TGF-β1 in the proximal tubule is stimulated by high glucose [8,9].…”
Section: Introductionmentioning
confidence: 99%